Gregg Fonarow, MD: Dr Fonarow is a consultant for Abbott Pharmaceuticals, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Eli Lilly and Company, Janssen Pharmaceuticals, Medtronic, Merck, Novartis, and Pfizer
Athletes in tested sports should avoid its use
For metabolic patients where cortisol dysregulation and poor deep sleep are common this represents a targeted upstream intervention on a major driver of insulin resistance, visceral fat, and impaired recovery
J Controlled Rel
100 IU = 1 ml, so 10 IU = 0.10 ml, regardless of what is in the syringe
But its been more than three decades since researchers began studying BPC-157, and public evidence remains dominated by animal- and cell-based papers and small human pilot studies